Xolair on Humana Basic Rx Plan (S5884-137)
omalizumab
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 4 per 28 days.
$1,460.54
Patient pays / month, after deductible
$1,921.79
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
XOLAIR PFS 75 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $5,842.14 for a month. Other covered strengths are listed below.
Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| XOLAIR PFS 75 mg/.5mL Injection, Solution | 5 | $1,480.00 | PA · 4 per 28 days |
| XOLAIR PFS 75 mg/.5mL Injection, Solution | 5 | $1,460.54 | PA · 4 per 28 days |
| XOLAIR PFS 150 mg/mL Injection, Solution | 5 | $3,336.51 | PA · 8 per 28 days |
| XOLAIR PFS 150 mg/mL Injection, Solution | 5 | $3,286.20 | PA · 8 per 28 days |
| XOLAIR 300 mg/2mL Injection, Solution | 5 | $3,383.32 | PA · 8 per 28 days |
| XOLAIR 300 mg/2mL Injection, Solution | 5 | $3,318.70 | PA · 8 per 28 days |
Other Asthma and COPD biologics on this plan
Verify with the plan before prescribing or filling. Member services: (800)281-6918. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5884-137